DAFNA Capital Management, LLC

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Stereotaxis, Inc.
STXS
$35.71M16.5513.68M0%+$00.87
Perspective Therapeutics, Inc.
CATX
$3.69B4.613.1MNew+$3.69B89.65
2seventy bio, Inc.
TSVT
$6.44M2.341.2M-16.82%-$1.3M0.16
AxoGen, Inc.
AXGN
$7.55M2.14935,8940%+$00.18
KalVista Pharmaceuticals, Inc.
KALV
$9.57M1.89806,973+34.27%+$2.44M0.23
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.